On July 5th, Gelunhui - ST Jingfeng (000908.SZ) released the second risk warning announcement that the company's stock may be terminated from listing. On July 5th, 2024, the closing price of Hunan Jingfeng Pharmaceutical Co., Ltd. stock has remained below 1 yuan for ten consecutive trading days. According to Article 9.2.1(4) of the Shenzhen Stock Exchange Listing Rules, if the company's stock closing price remains below 1 yuan for twenty consecutive trading days, there is a risk of the company's stock being terminated from listing.

According to Article 9.2.4 of the Shenzhen Stock Exchange Listing Rules, if the daily closing price of a listed company's stock remains below 1 yuan for ten consecutive trading days, the company should disclose the possibility of its stock being terminated from listing due to the stock price being lower than its face value and release a risk warning announcement daily until the relevant situation is resolved or the decision to terminate the listing of the company's stock is made by the Shenzhen Stock Exchange.

The company's net assets at the end of the audited period in 2023 were negative. Daxin Audit LLP (Special General Partnership) issued a negative opinion on the company's internal control audit report for 2023, and the company's stock is subject to additional risk warnings for delisting.

The net profit after deducting non-recurring gains and losses for the last three fiscal years has been negative, and the latest audit report shows that there is uncertainty about the company's ability to continue operating. The company's stock is subject to additional risk warnings for delisting. We urge investors to invest rationally and pay attention to risks.